CLEAR DPC

08/21/2026

Healthcare shouldn't feel like a race. In the traditional model, insurance hurdles and paperwork eat up the clock. With Direct Primary Care, we remove the barriers so you can focus on what matters: your patients, your family, and your peace of mind.

What would you do with more time in your day? Let's chat about how we can help you reclaim it.

05/11/2026

ORDERING RECOMMENDATIONS
Easily integrate HPV self-collection into your primary care setting
HPV self-collection is an effective way of closing the cervical cancer screening gap. According to the US Preventive Services Task Force, data on outcomes for patients screened with self-collected samples is comparable to outcomes on clinician-collected samples.1

HPV self-collection is simple to integrate into your primary care setting.

05/07/2026

Come on local DPC’s Cary, Apex and Holly Springs!!

https://www.facebook.com/share/1DwZbEknbe/?mibextid=wwXIfr

Vendor applications are now open for our 55+ Health & Wellness Fair!

Apply by Friday, July 17 for advanced consideration. Selected vendors will be notified by July 24, with a $50 fee due by July 31 to secure your spot.

Don’t miss your chance to be part of this great community event — apply today at https://www.apexnc.org/1076/Apex-55-Health-Wellness-Fair

04/27/2026

Provider Insights
Practical guidance to enable confident diagnostic decisions
Are you underestimating cardiovascular risk?

In most primary care settings, LDL-C remains the go-to marker for assessing cardiovascular disease (CVD) risk. But here’s the challenge:

Many patients who experience cardiac events have normal LDL-C levels.

So what’s missing?

Apolipoprotein B (apoB) offers a more complete picture.

ApoB measures the number of atherogenic particles—not just the cholesterol they carry—making it a stronger indicator of cardiovascular risk.

Elevated apoB levels are associated with significantly higher CVD risk—even when LDL-C appears controlled.


ApoB identifies individuals who have
a 50% higher risk of myocardial
infarction compared to expectations
of LDL-C testing.2

In fact, relying on LDL-C alone can underestimate risk, especially in patients with metabolic syndrome, diabetes, or elevated triglycerides.

What this means for your patients:
If apoB isn’t part of your testing strategy, you may be missing early warning signs—and opportunities for prevention.

Early detection leads to better outcomes.

Learn more about how apoB testing can improve your clinical decision-making:

04/06/2026

01/01/2026

Cheers to DPC this year big things are happening!! Let’s go